CARNITINE METABOLISM IN RtKWENI REYE SYNDROME DUE 1200 TO DEFEXYIVE ACEIYL-CoA DISPOSAL.I,nqeborq Kr+eqer and -ran L. Bieber. Wayne S t a t e Kmv. Detroit. A t e n m n t h o l d i n f a n t with m u l t i p l e Reye Syndrome-like a tt a c k s excreted during t h e i l l n e s s p-hydmxybutrate,acetoacetate and l a r g e munts of t h e following dicarboxylic acids: adipate, suberat(?,sebacate, ethylmalonare and q l u r a r a t r .Production o f C02 fror(1-1LC) a r ' .~( l ' -l~~)~a l r n i t a t e ar.?(l-1L~1Sur.~ratb was 83%. 5% and 50%, respectively. Acyl-CoA dehydrcgenase was normal. Ribof l a v i n therapy eliminated t h e dicarboxylic a c i d u r i a under o r d inary load conditions. C a r n i t i n e metabolism was studied because plasma c a r n i t i n e was low (22.2 p l / l ) and continued to decrease d e s p i t e t h e apparent b e n e f i c i a l e f f e c t of riboflavin.Urinary f r e e and s h o r t chain acylcarnitines(SCAC)were i n i t i a l l y 17.1 and
1 0 8 . 9 , m l / l ( N : 2 4 . 2 and 38.9),suggesting t h a t hypocarnitineinia was due t o u r i n a r y SCAC-loss(86-96% of t o t a l ) although absolute l o s s e s (227 p m l / g cr)were only m i l d l y elevated. Urine values normalized during i.v. glucose. A f t e r recovery from t h e a t t a c k and from dicarboxylic a c i d u r i a under r i b o f l a v i n therapy, o r a l c a r n i t i n e was given. This unveiled t h e p e r s i s t e n c e of t h e underl y i n g d e f e c t , because SCAC e x c r e t i o n increased t o 994 prml/g c r .
On a beef b m t h supplemented d i e t , SCAC excretion was 791-825 p m l / g c r . On a low-fat,low-pmtein d i e t without beef b r o t h SCAC was 140,uml/g cr.Acetylcarnitine was c o n s i s t e n t l y t h e majorurinary c a r n i t i n e ester:1052 nanom3l/ml(N:18.9) o r 620,umol/g c r .
This c a p a r e s with t h e a c e t y l c a r n i t i n e excretion of a d u l t s a f t e r 60hrs. s t a r v a t i o n ! and suggests a p a r t i a l block i n t h e disposal of acetyl-CoA.Reye Syn&om-like a t t a c k s may be p r e c i p i t a t e d by mitochondria1 trapping of Con-SH a s acetyl-CoA viz . acylCoA. 
CONTROL OF GLUCONEOGENFSs
G. L i n a r e l l i , Barry Smith, Heinz Paulus. Children's Hospital, Department of P e d i a t r i c s , University of C a l i f o r n i a , San Diego.
JM was a 1928 gram, 36-week small f o r g e s t a t i o n age male inf a n t born t o a Grav.-111, Para-0 mother. Hyperglycemia of 340 mg % was i d e n t i f i e d on a r r i v a l t o the nursery. Conventional approach changing from regular t o NPH i n s u l i n proved u n s a t i s f a c t o r y . Thus regular S.C. i n s u l i n (U20) was administered every 3 h r s pre-formula feeding based on Glucometer blood heel s t i c k glucose using a s l i d i n g s c a l e i n s u l i n dosage of 0.1 t o 0.5 u n i t s . Pen-Pump (U20 regular i n s u l i n ) was u t i l i z e d with manual administered pre-meal doses. I n s u l i n syringes were r e f i l l e d every 12 t o 24 h r s and needle s i t e s changed every 2 t o 3 days. A t r i a l on CPI Mode19100 ambulatory infusion pump was shown f e a s i b l e with continuous insul i n of 3 u n i t s f 2 4 hr r a t e (U10 i n s u l i n ) . JM was discharged a t 1 month of age on a Pen-Pump with home glucose monitoring pre-meals and s l i d i n g dose regular i n s u l i n . An infusion s i t e staph aureus c e l l u l i t i s resulted i n r e h o s p i t a l i z a t i o n . A new t r i a l of NPH (U10) b . i . d . proved e f f e c t i v e i n management by s i x weeks of age i n the range of 2.2 u n i t s b.i.d.
As the NPH i n s u l i n dose decreased from 2.2 U b . i . d . t o 0.3 U b . i . d . from 3 t o 6 mos. of l i f e , home glucose monitoring, hemoglobin AIC and u r i n e C-peptide were h e l p f u l guidelines. Urine C-peptide proved an e f f e c t i v e means of following r e s i d u a l pancreatic b e t a c e l l function with recovery of diabetes by 6 mos. of age. Timed measured urine samples every 2 weeks showed a r i s e from n i l C-pepcide t o 4.0 nglml with r e t u r n of pancreatic beta c e l l function Urine C-Peptide measured by 1mmu;ex Carbamoyl phosphate synthetase deficiency (CPSD) i s an autosoma1 recessive disorder of ureagenesis. Untreated p a t i e n t s with c o m~l e t e CPSD d i e as neonates of hv~erammonemia. Since CPS i s not expressed i n amniocytes, ~r e n a t a i ' detection i s limited t o utero l i v e r biopsy. To determine i f the CPS genes a r e abnormal i n f e c t e d s we analyzed nuclear DNA prepared from leukocytes o r f i b r o b l a s t s by hybridization t o r a t and human CPS cDNA sequences.
DNAs from 6 individuals a f f e c t e d with CPSD, 2 non-affected s i b s and 2 controls y f r e digested with Eco RI, Hind I11 o r Pst I and hybridized t o P labeled r a t CPS cDNA. No v a r i a t i o n s i n the number o r s i z e of hybridizing fragments were seen.
To enable linkage s t u d i e s DNAs from the 10 parents were digested with 12 d i f f e r e n t r e s t r i c t i o n endonucleases. Only a f t e r I digestion was a variation seen (23,15.5 and 13 kb bands i n some versus 23 kb i n o t h e r s ) . Using a smaller human CPS cDNA we detected three patterns 23, 23+13 and 13 kb. In one family both parents had the 23+13, 2 affected s i b s had only the 23 and a normal s i b had only t h e 13 kb fragment(s) i n agreement with simple Mendelian inheritance.
In 2 other families the affected had only the 23 kb fragment. The affected children i n t h e remaining 2 f a m i l i e s had 23+13 o r 13 kb patterns.
Our s t u d i e s suggest t h a t 1 ) large
d e l e t i o n s o r i n s e r t i o n s of the CPS genes were not detected; 2) the CPSD phenotype and the I derived r e s t r i c t i o n fragments co-segregate and 3 ) genetic heterogeneity e x i s t s i n CPSD. Growth f a i l u r e and hypercalciuria have been noted independently i n children with insulin-dependent diabetes m e l l i t u s (IDDM). W e evaluated growth and calcium metabolism in 175 IDDM children and 38 non-diabetic (ND) s i b s of s i m i l a r ages. Height was determined by 2 of t h e authors using a Stadiometer. Blood and urine were collected i n t h e AM before food and i n s u l i n had been ., ~ 1 0~~= 9 . 6 + . 0 2 . mg/dl p=NS), a1 k a l i n e hos hatase (~~=105.8+7:0 ' IU, IDDM 284.9c7.5 IU p<. O-mf n DP ND 20.0+1.8 ng/ml, IDDM=23.0*2.0 ng/ml p=NS) , F T J m 3 k 7 . i pgiml , IDDM=158.4+5.2 p=NS) , (ND=54k3.8 p e r c e n t i l e , IDDM=43.7t2.3 p e r c e n t i l e p<.05). Ca/CFcorrelated with coincident serum glucose r5.28 p<.0002, HbA1, r=.24 p<.0004, but not with serum Ca, a1 ka-1 i n e ~h o s~h a t a~e .
HYPERCALCIURIA AND G OWTH FAILURE
vitamin D o r PTH. CaICr correlated inverse1 v with ~t p b r c e n t i i e r=.20 p<.01. I DDM with Ca/Cr>NO range werg s h o r t e r 37k3.2 p e r c e n t i l e than ND 54k3.8 p e r c e n t i l e p<.Ol. Hyp e r c a l c i u r i a was associated with both poor glycemic control and growth f a i l u r e in IDDM chi1 dren. When coincident serum glucose, HbAlc and duration of IDDM a r e factored out of t h e a n a l y s i s of variance t h e CaICr continues t o have a negative c o r r e l a t i o n t o height p e r c e n t i l e . Hypercalciuria appears t o be an important fact o r i n the growth f a i l u r e associated with IDDM.
INHIBITION OF FATTY ACID OXIDATION BY SULFONYLUREAS.
1205 Kenneth McCormick, Robert S i c o l i , Margaret Williams.
(Spon. by Gilbert B. Forbes). University of Rochester Medical Center, Dept. of P e d i a t r i c s , Rochester NY.
Sulfonylureas p o t e n t i a t e the c e l l u l a r a c t i o n of i n s u l i h , not by changing membrane receptor number a s previously thought, but by unknown postbinding mechanisms. We investigated t h e d i r e c t e f f e c t s of tolazamide on f a t t y a c i d oxidation i n i s o l a t e d int a c t l i v e r mitochondria, prepared from fed and f a s t e d r a t s . Total ketone body formation and C02 production (%lo% of t o t a l oxidative products) were measured using 1 -l '~ palmitate. Ketogenesis r e s u l t s a r e expressed i n nmols/min/mg p r o t . (+ SEM).
.004 .04 .4 4 40 .33+.20 2.052.17 1.72+,0 1.61&.1T1.63+.17 .OOz.l8 2.10+_.21 2.00+.21 2.00+.15 1.96+.20 hanges i n C07 production p a r a l l e l e d those of ketone formation (data not shown). Only mitochondria from fed r a t s were s e n s i t i v e t o tolazamide I n h i b i t i o n of f a t t y a c i d oxi. dation; t h i s was dose dependent with a maximum a t t e n u a t i o n a t 4uglml. Carnitine a c y l t r a n s f e r a s e a c t i v i t y was unaffected by high dose tolazamide.
In the absence of i n s u l i n , sulfonylureas, a t l e v e l s below therapeutic (20-40ug/ml), a t t e n u a t e f a t t y acid oxidation i n hepatic mitochondria from fed r a t s . This i n h i b i t i o n occurs proximal t o a c e t y l CoA formation; perhaps these compounds a r e r e l a t e d to o r i n t e n s i f y a p u t a t i v e i n s u l i n mediator released a f t e r receptor occupation.
